Status:
COMPLETED
Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
Lead Sponsor:
National Multiple Sclerosis Society
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
21-80 years
Phase:
PHASE1
Brief Summary
This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.
Detailed Description
Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to...
Eligibility Criteria
Inclusion
- Chronic upper extremity motor deficit due to multiple sclerosis
Exclusion
- Relapse within 3 months of planned enrollment.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00695084
Start Date
March 1 2007
End Date
April 1 2008
Last Update
June 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35249